Seven Editora
##common.pageHeaderLogo.altText##
##common.pageHeaderLogo.altText##


Contact

  • Seven Publicações Ltda CNPJ: 43.789.355/0001-14 Rua: Travessa Aristides Moleta, 290- São José dos Pinhais/PR CEP: 83045-090
  • Principal Contact
  • Nathan Albano Valente
  • (41) 9 8836-2677
  • editora@sevenevents.com.br
  • Support Contact
  • contato@sevenevents.com.br

HOMOCYSTEINE IN PREGNANCY AS A PREDICTOR OF PRE-ECLAMPSIA

Vargas-Vera RM;
Cornejo-Gómez MP;
Alencastro-Placencia SA;
Feijoo-Espinosa MA;
Placencia-Ibadango MV;
Vargas-Silva KS;
Bravo GRJS;
Vargas-Silva KS;
Placencia-Ibadango SM;
Inciarte NEV;
Fernández-Mancero GX;
Valdivieso LL

Ramón Miguel Vargas-Vera

María Paulina Cornejo-Gómez

Saul Alexander Alencastro-Placencia

Milena Anabel Feijoo-Espinosa

Martha Verónica Placencia-Ibadango

Kalid Stefano Vargas-Silva

Gonzalo Rodrigo José Sarango Bravo

Kathiuska Stefany Vargas-Silva

Silvia Maribel Placencia-Ibadango

Noren Enrique Villalobos Inciarte

Gonzalo Xavier Fernández-Mancero

Luis Landívar Valdivieso


Keywords

Homocysteine
EP
Gestational hypertension
Hypertensive gestosis

Abstract

Background. For more than 3000 years, medical conditions known as hypertensive states of pregnancy have been described. Hippocrates described epileptic seizures, while in the first century Celsus linked epileptic seizures to fetal death. Galen distinguished between epilepsy and peripheral epilepsy. Maternal mortality due to epilepsy reaches 44% and perinatal mortality reaches 27.8%. Homocysteine is related to PE between 20 and 30%, and an increase in PE or hyperhomocysteine may be the result of a genetic defect in the enzyme methylenetetrahydrofolate reductase (MTFHR) that is involved in homocysteine synthesis. The purpose of this study was to identify homocysteine levels in pregnant women between 16 and 20 weeks as an indicator of the likelihood of developing preeclampsia. Material and method. - It was an observational, longitudinal and prospective research. The study population consisted of patients who attended the first prenatal care consultation between 16 and 20. weeks, the sample was randomized that included 312 patients who were determined to have serum homocysteine. Results. 270 patients (86.5% of the total) had a normal pregnancy. 27 patients (8.65%) developed gestational hypertension, 9 (2.88%) had mild PE, and 6 (1.9%) had none developed HELLP syndrome. Homocysteine levels in patients with preeclampsia were in the standard range (11.05). Conclusions. In the current analysis, the frequency of hypertensive disease in pregnancy was found to be 13.5%. There is no correlation found between homocysteine levels and the development of hypertensive disease during pregnancy.

 

DOI:https://doi.org/10.56238/sevened2024.031-023


Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2024 Ramón Miguel Vargas-Vera , María Paulina Cornejo-Gómez , Saul Alexander Alencastro-Placencia , Milena Anabel Feijoo-Espinosa, Martha Verónica Placencia-Ibadango , Kalid Stefano Vargas-Silva , Gonzalo Rodrigo José Sarango Bravo, Kathiuska Stefany Vargas-Silva , Silvia Maribel Placencia-Ibadango , Noren Enrique Villalobos Inciarte, Gonzalo Xavier Fernández-Mancero , Luis Landívar Valdivieso

Author(s)

  • Ramón Miguel Vargas-Vera
  • María Paulina Cornejo-Gómez
  • Saul Alexander Alencastro-Placencia
  • Milena Anabel Feijoo-Espinosa
  • Martha Verónica Placencia-Ibadango
  • Kalid Stefano Vargas-Silva
  • Gonzalo Rodrigo José Sarango Bravo
  • Kathiuska Stefany Vargas-Silva
  • Silvia Maribel Placencia-Ibadango
  • Noren Enrique Villalobos Inciarte
  • Gonzalo Xavier Fernández-Mancero
  • Luis Landívar Valdivieso